Adherence-Informed Clinical Trials to Optimize Drug Development And Enable Precision Medicine

Poor adherence to medicines in clinical trials can undermine the value of the trials; for example, by compromising estimates of the benefits and risks of a medicine. In this webinar, we highlight such consequences and also discuss approaches to tackle this problem from drug development to clinical practice.